Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Niacin compositions for reduction of amyloid beta peptide 42 (abeta 42) production and for treatment of Alzheimer's disease (AD)

Niacin compositions for reduction of amyloid beta peptide 42 (abeta 42) production and for treatment of Alzheimer's disease (AD)

US Patent 8541435 · Granted Sep 24, 2013

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Immunotherapeutic composition for prevention of obesity, nonalcoholic fatty live2025
Hyperimmunized egg product for treatment or prevention of coronavirus infection2025
Hyperimmunized egg product for treatment or prevention of coronavirus infection2023
Compositions for reducing Aβ 42 production and their use in treating alzheimer's2016
Compositions for reducing aβ 42 production and their use in treating alzheimer's2014
Methods for the treatment of diabetes-associated dyslipdemia2011
Medical devices employing triazine compounds and compositions thereof2008
Triazine compounds and their analogs, compositions, and methods2008
Methods and compositions of novel triazine compounds2008
Methods and compositions of novel triazine compounds2008
Methods and compositions of novel triazine compounds2008
Methods and compositions for detecting compounds that modulate inflammatory resp2007